纤维化-4指数(FIB-4)与类风湿关节炎患者的心血管风险和胰岛素抵抗相关
这项横断面研究纳入465例类风湿关节炎(RA)患者,计算FIB-4指数并评估其与疾病特征、血脂、亚临床颈动脉粥样硬化及胰岛素抵抗的关系。结果显示20%的RA患者FIB-4处于 indeterminate 或高风险范围,FIB-4与SCORE2心血管风险计算值、胰岛素抵抗及代谢综合征显著相关,但与颈动脉粥样硬化及RA疾病特征(包括疾病活动度)无关。
要点
- 20%的RA患者FIB-4指数提示不确定或高风险肝纤维化。
- FIB-4与SCORE2心血管风险计算值升高显著相关,但与颈动脉粥样硬化无关。
- FIB-4与胰岛素抵抗及代谢综合征显著相关,多变量分析后与RA疾病特征无关。
核心结论
- 高达20%的RA患者FIB-4指数异常,且该指数与心血管风险和胰岛素抵抗相关。
研究设计与样本
- 横断面研究,共纳入465例类风湿关节炎患者,进行疾病特征、完整血脂谱、人体测量、胰岛素抵抗指数(HOMA)、代谢综合征标准及颈动脉超声(内膜-中层厚度和斑块检测)等全面评估。
主要发现
- 20%的RA患者FIB-4评分提示不确定或高风险肝纤维化。
- FIB-4与心血管风险计算器SCORE2较高值显著相关,但与颈动脉粥样硬化无显著相关。
- FIB-4与胰岛素抵抗和代谢综合征显著相关。
- 多变量分析后,FIB-4与RA疾病特征(包括疾病活动度)无相关性。
关键数值与推荐
- FIB-4按低风险(<1.45)、不确定风险(1.45-3.25)和高风险(>3.25)分类。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The Fibrosis-4 index (FIB-4), a non-invasive tool for assessing liver fibrosis, has also been linked to cardiovascular (CV) risk in the general population. This connection is due to the association of chronic liver diseases, particularly fibrosis or non-alcoholic fatty liver disease, with systemic inflammation, metabolic syndrome and atherosclerosis. In this study, we aimed to calculate the FIB-4 index in patients with rheumatoid arthritis (RA), a condition associated with increased CV disease risk. We then examined its association with disease characteristics and CV comorbidities, including lipid profile, subclinical carotid atherosclerosis and insulin resistance indices. METHODS: A total of 465 RA patients were recruited in this cross-sectional study. They underwent comprehensive evaluations, including disease-related features, complete lipid profile, anthropometric measurements, insulin resistance indices (using HOMA), metabolic syndrome criteria, and carotid ultrasound for intima-media thickness and carotid plaque detection. FIB-4 was calculated and categorized into low (<1.45), indeterminate (1.45-3.25) and high (>3.25) risk for fibrosis. A multivariable linear regression analysis was performed to examine the associations between the disease characteristics and FIB-4. RESULTS: Twenty percent of RA patients had a FIB-4 score indicating indeterminate or high risk for hepatic fibrosis. FIB-4 was significantly associated with higher values of the cardiovascular risk calculator SCORE2 but not with carotid atherosclerosis. It was also significantly related to insulin resistance and metabolic syndrome. However, after multivariable analysis, FIB-4 did not correlate with RA disease characteristics, including disease activity. CONCLUSION: Up to 20% of RA patients show an abnormal FIB-4 index, which correlates with cardiovascular risk and insulin resistance.
引用
- Ferraz-Amaro I, Heras-Recuero E, de Vera-González A, et al. The Fibrosis-4 Index (FIB-4) correlates with cardiovascular risk and insulin resistance in patients with rheumatoid arthritis. Rheumatology (Oxford). 2025. PMID: 40397115. doi:10.1093/rheumatology/keaf263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。